Consumer goods group blames difficulties in developed markets and rising commodity costs
The Nurofen-owning company has struggled with the weakest performance in its history.
Photograph: Glenn Hunt/AAP
Reckitt Benckiser, the owner of brands including Durex and Nurofen, missed its 2017 profit expectations and said tough trading in developed markets and rising commodity costs were set to continue.
The consumer goods group reported higher sales in the last quarter on Monday, in line with expectations, and forecast an increase for this year as it looks to move on from a turbulent 2017.
It pointed to an improved performance at its recently acquired Mead Johnson …
Read the full article at: https://www.theguardian.com/business/2018/feb/19/nurofen-owner-reckitt-benckiser-misses-profit-forecast-tough-trading